Submitted by Anonymous (not verified) on 5 June 2026 - 12:00
Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia
Source:
Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia